S 3175 · 109th Congress 2005–2007, ended

Life-Saving Medicines Export Act of 2006

Latest action · May 25, 2006 Read twice and referred to the Committee on the Judiciary. (text of measure as introduced: CR S5247-5252)

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMay 25, 2006
  2. Passed SenateNot reached
  3. Passed HouseNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Life-Saving Medicines Export Act of 2006 - Allows the Director of the U.S. Patent and Trademark Office (USPTO) to issue a compulsory license to a generic manufacturer of a pharmaceutical product or a patented product needed to prevent or treat potentially life threatening public health problems for the purposes of manufacturing and exporting such pharmaceutical products to an eligible country. Allows exportation to a country that is a least developed country as designated by the United Nations (U.N.) or a country that lacks sufficient manufacturing capacities to produce the pharmaceutical product. Sets forth application requirements for compulsory licenses, including that the manufacturer sought a voluntary license from the patent holder.

Requires the Director to establish an office within USPTO to assist applicants and eligible counties, nongovernmental organizations, or nations likely to become eligible countries in identifying companies in the United States which could provide pharmaceutical products under this Act.

Sets forth formulas for calculating the royalty amount that the holder of a compulsory license must pay to the patent holder.

Allows the Director to grant a compulsory license to a generic manufacturer on an expedited basis for a limited period for a pharmaceutical product to address a national emergency or other circumstances of extreme urgency.

Declares that it is not patent infringement to manufacture and export a pharmaceutical product in accordance with this Act.

Requires the Director to establish the National Advisory Board on Implementation of the General Council Decision to provide advice and guidance regarding the implementation and administration of the compulsory licensing program established under this Act.

Cosponsors

Members who signed on, in the order they did.

No cosponsors are on file for this measure.

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
SenateJudiciary Committee
Referred May 25, 2006

Actions 3

Everything that happened, newest first.

  1. May 25, 2006Introduced in Senate
  2. May 25, 2006Sponsor introductory remarks on measure. (CR S5245-5247)
  3. May 25, 2006Read twice and referred to the Committee on the Judiciary. (text of measure as introduced: CR S5247-5252)

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
SenateDebate and remarks S5245–S5247Text printed S5247–S5252Patrick J. Leahy D-VT (text)May 25, 2006

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
A bill to amend title 35, United States code, with respect to establishing procedures for granting authority to the Under Secretary for Commerce for Intellectual Property and Director of the Patent and Trademark Office to grant compulsory patent licenses for exporting patented pharmaceutical products to certain countries consistent with international commitments made by the United States, and for other purposes.
Short Titles as Introduced
Life-Saving Medicines Export Act of 2006

Subjects

Assigned by the Library of Congress. Policy area: Commerce.

Text 1

Each version as it was printed, newest first.

  1. May 25, 2006Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.